These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Manifesting heterozygotes in McArdle's disease: clinical, morphological and biochemical studies in a family. Manfredi G; Silvestri G; Servidei S; Ricci E; Mirabella M; Bertini E; Papacci M; Rana M; Tonali P J Neurol Sci; 1993 Mar; 115(1):91-4. PubMed ID: 8468596 [TBL] [Abstract][Full Text] [Related]
29. A splice-site mutation causing ovine McArdle's disease. Tan P; Allen JG; Wilton SD; Akkari PA; Huxtable CR; Laing NG Neuromuscul Disord; 1997 Jul; 7(5):336-42. PubMed ID: 9267848 [TBL] [Abstract][Full Text] [Related]
30. Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease. Tsujino S; Shanske S; Valberg SJ; Cardinet GH; Smith BP; DiMauro S Neuromuscul Disord; 1996 Jan; 6(1):19-26. PubMed ID: 8845714 [TBL] [Abstract][Full Text] [Related]
31. Mcardle's disease. A case report. Dirik E; Taşkin F; Eroğlu Y; Büyükgebiz B; Selamzade M; Cevik NT Turk J Pediatr; 1996; 38(3):355-9. PubMed ID: 8827906 [TBL] [Abstract][Full Text] [Related]
32. [McArdle's disease without typical symptoms]. Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931 [TBL] [Abstract][Full Text] [Related]
33. Two homozygous mutations (R193W and 794/795 delAA) in the myophosphorylase gene in a patient with McArdle's disease. Martín MA; Rubio JC; Campos Y; Vílchez J; Cabello A; Arenas J Hum Mutat; 2000 Mar; 15(3):294. PubMed ID: 10679948 [TBL] [Abstract][Full Text] [Related]
34. Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro. Pari G; Crerar MM; Nalbantoglu J; Shoubridge E; Jani A; Tsujino S; Shanske S; DiMauro S; Howell JM; Karpati G Neurology; 1999 Oct; 53(6):1352-4. PubMed ID: 10522901 [TBL] [Abstract][Full Text] [Related]
35. Resolution of a mispaired secondary structure intermediate could account for a novel micro-insertion/deletion (387 insA/del 8 bp) in the PYGM gene causing McArdle's disease. Martín MA; Rubio JC; García A; Fernández MA; Campos Y; Krawczak M; Cooper DN; Arenas J Clin Genet; 2001 Jan; 59(1):48-51. PubMed ID: 11168025 [TBL] [Abstract][Full Text] [Related]
36. McArdle's disease with late-onset symptoms: case report and review of the literature. Felice KJ; Schneebaum AB; Jones HR J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316 [TBL] [Abstract][Full Text] [Related]
37. McArdle's disease: a rare frameshift mutation in exon 1 of the muscle glycogen phosphorylase gene. Bartram C; Edwards RH; Clague J; Beynon RJ Biochim Biophys Acta; 1994 Jul; 1226(3):341-3. PubMed ID: 8054367 [TBL] [Abstract][Full Text] [Related]
38. Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase. Gospe SM; El-Schahawi M; Shanske S; Bruno C; DiMauro S; Hoye E; Walsh DA; Gorin FA Neurology; 1998 Oct; 51(4):1228-9. PubMed ID: 9781574 [No Abstract] [Full Text] [Related]
39. McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote. Schmidt B; Servidei S; Gabbai AA; Silva AC; de Sousa Bulle de Oliveira A; DiMauro S Neurology; 1987 Sep; 37(9):1558-61. PubMed ID: 3476861 [TBL] [Abstract][Full Text] [Related]
40. McArdle's disease: biochemical and molecular genetic studies. Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]